Molecular Profiles has entered into a strategic alliance with Onyx Scientific, combining services that will span initial drug discovery through to early and late phase manufacturing.
Customers from both companies will have access to a wider range of services including Onyx Scientific’s API production and initial solid state screening, and Molecular Profiles’ formulation and analytical development and early phase clinical trial manufacturing. Additionally, Onyx Scientific has sites in India providing late-stage clinical trial and commercial manufacturing services.
Denise Bowser, commercial director at Onyx Scientific, said, “We are excited that the combination of the two companies will be able to offer customers the full range of chemistry and formulations services. Technical teams across these two best-in-class organizations will be routinely working together and our customers can rest assured that they will receive a seamless service throughout their drug discovery and development programs.”
Claire Madden-Smith, commercial director at Molecular Profiles, said, “We are delighted to have partnered with Onyx Scientific and look forward to realizing the benefits of this strategic alliance. Our customers are now able to access services ranging from API production through to formulation development and late stage manufacturing, providing flexibility and the opportunity to experience a consistent delivery across these stages.”